Patients, Data, Scientists. Connected.
Discover how global biopharma and biotech companies leverage Genedata Profiler®, the 2022 Bio-IT Innovative Practices award-winning solution, to optimize translational and clinical research pipelines and advance the development of transformative precision medicine.
This partnership provides us with innovative approaches to drive the integration of biomarker data within and across our clinical programs including the digitalizing of translational workflows associated with clinical studies.
Paul Moore, Ph.D.
Vice-President of Immunology and Cell Biology
With the scientific support of Genedata and its Genedata Profiler software, Egis has developed the PREDYSTIC® Infliximab RA Kit to guide the treatment of RA patients, allowing therapies to be matched to the patients who will derive true benefits from treatment.
Zsolt Holló, PhD.
Head of the Center of Biological Business Development and Technology
The Genedata Profiler platform is used productively in a validated environment and is helping to democratize access to integrated data in the translational research and clinical settings.
Hisham Hamadeh, Ph.D.
Vice President, Global Head of Data Sciences
Working closely with Genedata, we have generated a digital biomarker research platform that will enable Merck scientists to better utilize clinical and translational data to generate innovative ideas for new biomarkers and drug targets.
Joern Peter Halle
Head of Immuno-oncology and External Innovation
We are pleased to have found a reliable partner who provided us with expert knowledge in big multi-omics data analysis to accelerate our search for precision biomarkers to prognosticate disease course and to guide early and effective personalized treatment decisions.
Andrés Hurtado-Lorenzo, Ph.D.
Senior Director of Translational Research
We chose Genedata Profiler because it is the end-to-end enterprise software able to harmonize our dispersed data analysis pipelines, enhancing our capacity to analyze large amounts of high-dimensional ‘omics data emerging from our rapidly growing number of translational and clinical research projects.
Department Manager of Clinical Pharmacology
As we expect our clinical and pre-clinical programs and pipeline to continue to grow, we look forward to utilizing Genedata Profiler and Genedata Managed IT Services to assist us in our mission to develop safe, targeted, effective therapeutics for cancer patients.
John de Kruif, Ph.D.
Chief Technology Officer
Read Our Latest Press Releases
Read Our Blog Articles
Unlocking the Power of Posit and R for Precision Medicine Development
Marie-Ange Kouassi & Hagen Klett
February 27, 2023
World Cancer Day at Genedata
Jana Hersch, Marie-Ange Kouassi, Justyna Lisowska, Jason Smith, Ada Yee
February 4, 2022